+1,067.9%
NVDL vs CME
+100.9%
+967.0%
-67.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | CME | Excess | Alpha |
|---|---|---|---|---|
| 1D | -6.0% | -0.4% | -5.6% | -6.3% |
| 7D | -25.3% | -1.8% | -23.5% | -26.0% |
| 30D | -53.6% | +5.7% | -59.3% | -52.0% |
| 3M | -56.4% | +14.8% | -71.1% | -52.8% |
| 6M | -60.0% | +2.7% | -62.7% | -58.9% |
| YTD | -48.1% | +17.5% | -65.5% | -42.7% |
| 1Y | -46.4% | +15.4% | -61.8% | -41.3% |
| 3Y | +204.3% | +65.2% | +139.1% | +273.1% |
| All | +1,067.9% | +100.9% | +967.0% | +1,119.3% |
Cumulative growth
Daily Returns
Daily percentage return beside CME.
Daily Out/Under-Performance
Portfolio return minus CME return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CME return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded CME wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling